340 related articles for article (PubMed ID: 21807514)
1. Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.
Li X; Zhao WL; Jiang JD; Ren KH; Du NN; Li YB; Wang YX; Bi CW; Shao RG; Song DQ
Bioorg Med Chem Lett; 2011 Sep; 21(18):5251-4. PubMed ID: 21807514
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
Xu Y; Jing D; Chen R; Rashid HU; Jiang J; Liu X; Wang L; Xie P
Bioorg Med Chem; 2018 Aug; 26(14):4136-4144. PubMed ID: 30007563
[TBL] [Abstract][Full Text] [Related]
3. Novel N-substituted sophoridinol derivatives as anticancer agents.
Bi CW; Zhang CX; Li YH; Tang S; Deng HB; Zhao WL; Wang Z; Shao RG; Song DQ
Eur J Med Chem; 2014 Jun; 81():95-105. PubMed ID: 24826818
[TBL] [Abstract][Full Text] [Related]
4. Novel α, β-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking and Anti-Cancer Activities.
Xu Y; Wu L; Dai H; Gao M; Ur Rashid H; Wang H; Xie P; Liu X; Jiang J; Wang L
Molecules; 2017 Nov; 22(11):. PubMed ID: 29135958
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
Li DD; Dai LL; Zhang N; Tao ZW
Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
Wang Z; Wu M; Wang Y; Li Z; Wang L; Han G; Chen F; Liu Y; Wang K; Zhang A; Meng L; Wang Q
Eur J Med Chem; 2012 May; 51():250-8. PubMed ID: 22417638
[TBL] [Abstract][Full Text] [Related]
12. QSAR prediction, synthesis, anticancer evaluation, and mechanistic investigations of novel sophoridine derivatives as topoisomerase I inhibitors.
Zhu L; Yu Y; Ma Y; Shi Y; Kowah JAH; Wang L; Yuan M; Liu X
Fitoterapia; 2024 Jun; 175():105921. PubMed ID: 38561052
[TBL] [Abstract][Full Text] [Related]
13. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids.
Lee S; Hwang S; Yu S; Jang W; Lee YM; Kim S
Arch Pharm Res; 2011 Jul; 34(7):1065-70. PubMed ID: 21811912
[TBL] [Abstract][Full Text] [Related]
15. Expedient synthesis and structure-activity relationships of phenanthroindolizidine and phenanthroquinolizidine alkaloids.
Chuang TH; Lee SJ; Yang CW; Wu PL
Org Biomol Chem; 2006 Mar; 4(5):860-7. PubMed ID: 16493470
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of gibberellin derivatives with anti-tumor bioactivities.
Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H
Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH
Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
